<DOC>
	<DOCNO>NCT00520377</DOCNO>
	<brief_summary>The primary objective area newly form bone ( % ) assess histomorphometry either MD05 beta-TCP .</brief_summary>
	<brief_title>Pilot Study Safety Efficacy MD05 Comparison With Beta-TCP Patients Undergoing Sinus Floor Augmentation</brief_title>
	<detailed_description />
	<criteria>Patients require twostage unilateral maxillary sinus floor augmentation ( sinus lift ) case insufficient bone height area posterior maxilla , prior insertion dental implant Residual bone height site plan implantation &gt; 1 mm &lt; 5 mm Male female outpatient , 18 75 year old Female patient must infertile ( either sterilize postmenopausal ) . If patient 's menopausal status screen uncertain , level follicle stimulate hormone ( FSH ) determine . Patients FSH level &gt; 25 IU/l absence menstrual bleeding &gt; 6 month satisfy definition postmenopausal status . Patient give informed consent . Women childbearing potential , lactating woman Participation another clinical study within 30 day prior study start Previous participation study Last dental extraction ( maxilla , posterior canine ) within last 3 month Failed sinus lift surgery previous eradictive maxillary sinus surgery Simultaneously bilateral sinus lift Legal incompetence restrict legal competence Alcoholism , drug dependency , smoke Acute chronic infection application site , e.g. , sinusitis Known infection human immunodeficiency virus ( HIV ) , hepatitis B virus ( HBV ) , hepatitis C virus ( HCV ) Severe allergic rhinitis require permanent medication ( Rosenlicht 1999 ) Known intolerance hypersensitivity betaTCP rhGDF﷓5 Presence local systemic malignant disease history local systemic malignant disease past 5 year Patients require chemo radiotherapy Previous current radiotherapy head Chronic liver disorder Impaired renal function Uncontrolled , insulindependent diabetes mellitus Clinically relevant symptom thyroid dysfunction Severe hypertension ( RRdiast &gt; 110 mmHg ) ; Clinically relevant cardiovascular disease Systemic bone disease illness influence bone metabolism , Clinically relevant blood coagulation disorder , Leukopenia &lt; 3.500 leukocytes/µL Previous current treatment systemic corticosteroid Previous current therapy drug influence bone metabolism Previous current treatment immunosuppressant medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Sinus Lift Surgery</keyword>
	<keyword>Sinus Floor Augmentation</keyword>
	<keyword>Insufficient Bone Height</keyword>
</DOC>